Herein, we consider venous immunothrombotic mechanisms in SARS-CoV-2 infection and
anti-SARS-CoV-2 DNA vaccination. Primary SARS-CoV-2 infection with systemic viral RNA …

COVID-19 pandemic has impacted the world population, with a high rate of morbidity and
mortality. While the evidence to date has attempted to describe clinical feature of acute …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of the
Betacoronavirus genus (which also includes SARS 1 and Middle East respiratory syndrome …

Introduction Coronavirus disease of 2019 (COVID-19) is a lower respiratory tract infection
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease …

Objective To perform a scoping review of how patients with COVID-19 are affected by acute
limb ischaemia (ALI) and evaluate the recommendations of the 2020 ESVS ALI Guidelines …

Acute mesenteric ischemia is a rare but extremely severe complication of SARS-CoV-2
infection. The present review aims to document the clinical, laboratory, and imaging findings …

Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

In the spring of 2021, reports of rare and unusual venous thrombosis in association with the
ChAdOx1 and Ad26. COV2. S adenovirus-based coronavirus vaccines led to a brief …

Abstract Objective/Background Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection has been associated with thrombotic complications such as deep vein …

Central retinal vein occlusion (CRVO) and other thromboembolic events have been
extensively documented after infections with SARS-Cov2 [1, 2]. We observed a 50-year-old …